Isoquinolone inhibitors of factor Xa
US6469026B2 · kind B2 · utility
21Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2001 |
| Grant date | Oct 22, 2002 |
| Priority date | — |
| Expiry date | Mar 26, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/24
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds of formula I: including its pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa is described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating conditions in mammals characterized by undesired thrombosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.